Showing 1311-1320 of 5688 results for "".
Shielding Your Wealth From Potential Liability
https://modernod.com/topics/business/shielding-your-wealth-from-potential-liability-1/38679/The basics of a solid asset protection plan.Blepharitis Treatment Tactics
https://modernod.com/topics/ocular-surface/blepharitis-treatment-tactics/38422/Strategies for maintaining patient compliance.Complex Management of a Patient With a Coinfection
https://modernod.com/mod-issues/2022-jan-feb/complex-management-of-a-patient-with-a-coinfection/38370/This patient had a penicillin allergy and both neurosyphilis and HIV.Global Perspectives
https://modernod.com/mod-issues/2022-jan-feb/global-perspective/38363/Contact Lens Fitting for Presbyopia
https://modernod.com/topics/contact-lenses/contact-lens-fitting-for-presbyopia/38301/Five steps to success.Not Your Typical Scleritis
https://modernod.com/topics/business/not-your-typical-scleritis/38149/What ODs should know about granulomatosis with polyangiitis.The Art and Science of Referrals
https://modernod.com/topics/business/the-art-and-science-of-referrals/39071/Ensure that your patients receive the care they need—even when it falls outside of your practice pattern or capability.What It Takes to Be a Successful Medical Eye Care Practice
https://modernod.com/topics/business/what-it-takes-to-be-a-successful-medicaleye-care-practice/37962/You can start by looking for medical diagnoses in your existing patient base.Neuro: An Emerging Subset of Optometry?
https://modernod.com/topics/neuro-optometry/neuro-an-emerging-subset-of-optometry/37896/If you’re interested in visual processing pathways, specializing in neuro-optometry might be for you.Alcon Acquires Staar for $1.5 Billion
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-acquires-staar-for-15-billion/37096/Alcon makes a major acquisition to expand its refractive portfolio; the CEO of Lenz Therapeutics joins us to discuss the FDA approval of a new presbyopia drop; and the optical industry braces for major changes as new reciprocal tariffs are set to begin this week. Learn more about your ad choices.